These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23698763)

  • 21. Botulinum-induced muscle paralysis alters metabolic gene expression and fatigue recovery.
    Gorin F; Herrick K; Froman B; Palmer W; Tait R; Carlsen R
    Am J Physiol; 1996 Jan; 270(1 Pt 2):R238-45. PubMed ID: 8769807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides.
    Sadick NS; Herman AR
    Dermatol Surg; 2003 Apr; 29(4):340-7. PubMed ID: 12656810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
    Houser MK; Sheean GL; Lees AJ
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of anastomotic thrombosis by botulinum toxin B after acute injury in a rat model.
    Janz BA; Thomas PR; Fanua SP; Dunn RE; Wilgis EF; Means KR
    J Hand Surg Am; 2011 Oct; 36(10):1585-91. PubMed ID: 21855233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic effects of different doses of botulinum toxin A injection on tiptoe deformation in children with cerebral palsy].
    Niu GH; Zhang XL; Zhu DN; Cai ZJ; Li SS; Zhang W
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):720-4. PubMed ID: 25008880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis.
    Kim HS; Hwang JH; Jeong ST; Lee YT; Lee PK; Suh YL; Shim JS
    Dev Med Child Neurol; 2003 Mar; 45(3):200-6. PubMed ID: 12613778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox).
    Fortuna R; Vaz MA; Youssef AR; Longino D; Herzog W
    J Biomech; 2011 Jan; 44(1):39-44. PubMed ID: 20828699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of insulin-like growth factor I, insulin-like growth factor binding proteins, and collagen mRNA in mechanically loaded plantaris tendon.
    Olesen JL; Heinemeier KM; Haddad F; Langberg H; Flyvbjerg A; Kjaer M; Baldwin KM
    J Appl Physiol (1985); 2006 Jul; 101(1):183-8. PubMed ID: 16782835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis.
    Qiao D; Xu J; Le C; Huang E; Liu C; Qiu P; Lin Z; Xie WB; Wang H
    Toxicol Lett; 2014 Nov; 230(3):444-53. PubMed ID: 25127757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simulation of effects of botulinum toxin on muscular mechanics in time course of treatment based on adverse extracellular matrix adaptations.
    Turkoglu AN; Yucesoy CA
    J Biomech; 2016 May; 49(7):1192-1198. PubMed ID: 26994785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth cartilage expression of growth hormone/insulin-like growth factor I axis in spontaneous and growth hormone induced catch-up growth.
    Brito I; Gil-Peña H; Molinos I; Loredo V; Henriques-Coelho T; Caldas-Afonso A; Santos F
    Growth Horm IGF Res; 2012; 22(3-4):129-33. PubMed ID: 22583947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
    Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL
    Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin-induced paralysis leads to slower myosin heavy chain isoform composition and reduced titin content in juvenile rat gastrocnemius muscle.
    Legerlotz K; Matthews KG; McMahon CD; Smith HK
    Muscle Nerve; 2009 Apr; 39(4):472-9. PubMed ID: 19260067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety.
    Roger Aoki K
    Toxicon; 2002 Jul; 40(7):923-8. PubMed ID: 12076646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles.
    Lange F; van Weerden TW; van der Hoeven JH
    Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction of Malocclusion by Botulinum Neurotoxin Injection into Masticatory Muscles.
    Seok H; Kim SG
    Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29301317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ethanol on the intraovarian insulin-like growth factor-1 system in the prepubertal rat.
    Srivastava VK; Hiney JK; Dees WL
    Alcohol Clin Exp Res; 1999 Feb; 23(2):293-300. PubMed ID: 10069559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A reduces the expression of transient receptor potential melastatin 3 and transient receptor potential vanilloid type 4 in the trigeminal subnucleus caudalis of a rat model of trigeminal neuralgia.
    Zhang Y; Su Q; Lian Y; Chen Y
    Neuroreport; 2019 Jul; 30(10):735-740. PubMed ID: 31116130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.